Vesicoureteral Reflux Affects 1% of Newborns and Can Cause Permanent Kidney Damage

Vesicoureteral reflux (VUR) represents a critical pediatric urological condition where urine flows backward from the bladder to the upper urinary tract, potentially causing permanent kidney damage. This comprehensive review reveals VUR affects approximately 1% of all newborns, making it the most prevalent urological abnormality in neonates, with rates climbing to 15% among infants diagnosed with prenatal hydronephrosis.

The condition demonstrates striking demographic patterns and genetic predisposition. VUR occurs three times more frequently in White versus Black patients and twice as often in females, except in cases identified through prenatal screening where males predominate. Most significantly, up to two-thirds of children born to mothers with primary VUR will develop the condition, indicating strong hereditary components.

Diagnostic approaches center on voiding cystourethrogram (VCUG) as the gold standard, with VUR graded from I to V based on severity. Lower grades (I-II) show 75% spontaneous resolution by age 5, while higher grades require more aggressive management. Treatment strategies have evolved from routine antibiotic prophylaxis to individualized approaches considering patient age, VUR grade, and risk factors.

Current management controversies focus on antibiotic prophylaxis effectiveness versus resistance development. Recent randomized trials support prophylaxis benefits in high-risk infants, particularly those with grades IV-V VUR or bladder dysfunction. However, some European guidelines question routine prophylaxis due to modest benefits versus resistance risks. Alternative approaches include intravesical antimicrobial instillation and surgical intervention for refractory cases, though spontaneous resolution remains common in younger patients with lower-grade disease.